gabexate has been researched along with HIV Infections in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manfredi, R | 1 |
| Calza, L | 1 |
| Chiodo, F | 1 |
1 other study available for gabexate and HIV Infections
| Article | Year |
|---|---|
Gabexate mesilate and/or octreotide in human immunodeficiency virus-associated pancreatic abnormalities.
Topics: Adult; Case-Control Studies; Drug Combinations; Female; Gabexate; HIV Infections; Humans; Male; Octr | 2002 |